Identification of differentially methylated BRCA1 and CRISP2 DNA regions as blood surrogate markers for cardiovascular disease.
Istas, Geoffrey; Declerck, Ken; Pudenz, Maria; Szic, Katarzyna Szarc Vel; Lendinez-Tortajada, Veronica; Leon-Latre, Montserrat; Heyninck, Karen; Haegeman, Guy; Casasnovas, Jose A; Tellez-Plaza, Maria; Gerhauser, Clarissa; Heiss, Christian; Rodriguez-Mateos, Ana; Berghe, Wim Vanden.
; 7(1): 5120, 2017 07 11.
Artigo em Inglês | MEDLINE | ID: mdl-28698603
Comprehensive annotation of splice junctions supports pervasive alternative splicing at the BRCA1 locus: a report from the ENIGMA consortium.
Context Matters: RNF168 Connects with PALB2 to Rewire Homologous Recombination in BRCA1 Haploinsufficiency.
Risk-Reducing Bilateral Salpingo-Oophorectomy for BRCA Mutation Carriers and Hormonal Replacement Therapy: If It Should Rain, Better a Drizzle than a Storm.
Methylation of the BRCA1 promoter in peripheral blood DNA is associated with triple-negative and medullary breast cancer.
Genome instability in blood cells of a BRCA1+ breast cancer family.
BRCA1 recruitment to transcriptional pause sites is required for R-loop-driven DNA damage repair.
Factors forming the BRCA1-A complex orchestrate BRCA1 recruitment to the sites of DNA damage.
In situ hybridization chain reaction mediated ultrasensitive enzyme-free and conjugation-free electrochemcial genosensor for BRCA-1 gene in complex matrices.
BRCA1 and its toolbox for the maintenance of genome integrity.
PARP Inhibitors for Cancer Therapy.